Advertisement
Top 10 winter foods
Use food to your advantage this winter - the right ones can cut your risk for colds and flu.
Users and abusers
Yes, substance abuse can happen to anyone. Read what our forum users have to say.
     TERMS     GET A DAILY HEALTH TIP  
  
MAKE HEALTH24 YOUR HOMEPAGE   
H24 NEWS MEDICAL SCHEMES DIET FITNESS NATURAL MAN WOMAN SEX PREGNANCY CHILD TEEN SUN
FOCUS CENTRES MEDS ORAL PET MIND GRAPHICS VIDEOS ANTI-AGEING WIN TOOLS EXPERTS TALK FIND


Prostate
Fish oil may help prostate
Last updated: Friday, June 22, 2007
A new study with mice suggests that diets high in omega-3 fatty acids from fish might help slow prostate cancer.

The comparable levels of dietary omega-3s used in the study "are much higher than the average Western diet, but they are not unachievable," said senior researcher Yong Chen, a professor of cancer biology at Wake Forest University School of Medicine in Winston-Salem, North Carolina.

Advertisement
Omega-3 fatty acids - especially the "long-chain" forms found in oily fish - have become the latest nutrition superstars, with studies suggesting they can help prevent heart disease and even cancer.

Mechanism still unclear
The exact mechanism driving the purported anti-cancer effect is still unclear, Chen said. One leading theory contends that specific cellular enzymes metabolise omega-3s in ways that retard malignancy.

However, Chen's team is investigating a much lesser-known mechanism.

"It turns out that [long-chain] omega-3 fatty acids might modulate apoptosis - a form of cell death," he said.

Cancer cells spread in two ways: either they proliferate uncontrollably, or they bypass natural signalling that tells them to commit suicide, or apoptosis.

Helping cells commit suicide
"It turns out that a key molecule - that happens to be called 'Bad' - may be involved in this process," Chen said. His team now believes that long-chain omega-3s interact favourably with Bad to push cancer cells back into a normal apoptosis.

In their study, the researchers fed mice diets high in both omega-3 fatty acid and the less-healthy omega-6 fatty acids. These mice were genetically engineered to lack the Pten tumour suppressor gene, leaving them highly prone to prostate tumours. Dysfunctional Pten plays a key role in about one-third of human prostate cancers, so this mouse is a great model for human disease, Chen said.

As expected, mice with functioning Pten did not develop prostate cancer, the researchers said.

On the other hand, rodents whose Pten was switched off typically developed prostate tumours. However, 60 percent of these mice survived if they were fed a high omega-3 diet, compared to just 10 percent given a low omega-3 diet. None of the mice given the high omega-6 diet survived, the team noted.

There was another wrinkle to the study. In the past, it has been tough for researchers to tease out the effects of omega-6 and omega-3 fatty acids, which usually occur together in foods. But Chen's team introduced another gene into the Pten-less mice. This gene caused the mice to convert omega-6 fatty acids into the omega-3 form, thereby limiting this confounding factor.

"That's really a big strength of this study; nobody had really ever done that before," Chen said.

The study was published on June 21 in the online edition of the Journal of Clinical Investigation.

According to Chen, the study suggests that diets high in long-chain omega-3 fatty acids might give men an edge against prostate cancer.

Not everyone is convinced
"Recent large reviews and meta-analyses tend to suggest no major effects of fish [intake] on cancer risk," said Paul Terry, assistant professor in the department of epidemiology at the Emory University School of Public Health, in Atlanta.

"The fact that they [the Wake Forest researchers] identified and addressed another potential mechanism in their study is certainly helpful," he added. However, he said, "how this mechanism relates to the many others identified and shown in studies to be possibly important remains unclear."

Terry said rodent studies can only tell scientists so much, and "clinical trials in humans of long-chain omega-3 fatty acids and tumour characteristics, for example, are relatively scarce. This study, and others, provides some more rationale for conducting such trials."

Not all omega-3s are equal
For his part, Chen said it's important that consumers realise that not all omega-3s are created equal in terms of their potential health benefits.

"In this study, we are only referring to the long-chain form" found in oily fish, such as mackerel, herring, albacore tuna and salmon, he said. Other, shorter-chain varieties can be found in flaxseed and plant sources, but their impact, if any, on cancer is even less clear.

"We are doing a type of study right now to see whether there is any difference," Chen said. – (HealthDayNews)

Read more:
Prostate Centre
Fish oil vs. mental decline

June 2007
 
Print this article on
 Rate this article
Poor 1 2 3 4 5 Excellent

 JOBS
Operations Manager
R20,000-25,000 Per Month Cost To Company Incl Benefits
Gauteng - East Rand
Financial Accountant: CA(SA)
R400,000-500,000 Per Annum Cost To Company
Gauteng - Johannesburg
Key Account Manager
Gauteng
Java Developer-CT
Western Cape - Cape Town
Java Developer-Jozi
Gauteng
Account Manager
R460,000-540,000 Per Annum Cost To Company Plus Benefits
Gauteng
Account Manager
R460,000-540,000 Per Annum Market Related Plus Benefits
South Africa
Case Manager
R210,000-220,000 Per Annum Negotiable
Gauteng - Pretoria
 Today's top stories
  • REGULAR SEX=BETTER ERECTIONS
  • PREGNANT MAN GIVES BIRTH
  • WOMAN'S ACCENT CHANGES AFTER STROKE
  • LIFES GOOD FOR MICE ON RED WINE
  • ALLEGED FRAUD CASE POSTPONED
  • CANCER CELLS EXTRACTED FROM BLOOD
  • DIABETICS GROGGY AFTER FATTY MEAL
     
    Subscribe to...
    *Daily tip
    *Weekly tip
    Want to subscribe to our newsletters?
    Click here.
    *Stand a chance to win R1000 every month!

     
     
     
     
    Advertisement

     Sponsored links
     Health24 links

    Advertisement

     

    © Health24 2000-2008. All rights reserved
      
    We comply with the HONcode standard for trustworthy health
    information.
    Verify here.